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Cyclin-dependent kinase 5The studies of signaling mechanisms involved in the disruption of the cytoskeleton homeostasis were per-
formed in a model of quinolinic acid (QUIN) neurotoxicity in vitro. This investigation focused on the phos-
phorylation level of intermediate ﬁlament (IF) subunits of astrocytes (glial ﬁbrillary acidic protein — GFAP)
and neurons (low, medium and high molecular weight neuroﬁlament subunits — NFL, NFM and NFH, respec-
tively). The activity of the phosphorylating system associated with the IFs was investigated in striatal slices of
rat exposed to QUIN or treated simultaneously with QUIN plus glutamate receptor antagonists, calcium chan-
nel blockers or kinase inhibitors. Results showed that in astrocytes, the action of 100 μM QUIN was mainly
due to increased Ca2+ inﬂux through NMDA and L-type voltage-dependent Ca2+ channels (L-VDCC). In neu-
ronal cells QUIN acted through metabotropic glutamate receptor (mGluR) activation and inﬂux of Ca2+
through NMDA receptors and L-VDCC, as well as Ca2+ release from intracellular stores. These mechanisms
then set off a cascade of events including activation of PKA, PKCaMII and PKC, which phosphorylate head do-
main sites on GFAP and NFL. Also, Cdk5 was activated downstream of mGluR5, phosphorylating the KSP re-
peats on NFM and NFH. mGluR1 was upstream of phospholipase C (PLC) which, in turn, produced
diacylglycerol (DAG) and inositol 3,4,5 triphosphate (IP3). DAG is important to activate PKC and phosphory-
late NFL, while IP3 contributed to Ca
2+ release from internal stores promoting hyperphosphorylation of KSP
repeats on the tail domain of NFM and NFH. The present study supports the concept of glutamate and Ca2+
contribution in excitotoxic neuronal damage provoked by QUIN associated to dysfunction of the cytoskeleton
homeostasis and highlights the differential signaling mechanisms elicited in striatal astrocytes and neurons.
© 2011 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Quinolinic acid (QUIN) is an intermediate of the kynurenine path-
way, a central route in tryptophan (TRP) metabolism in most mamma-
lian tissues. The kynurenine pathway has been demonstrated to be
involved inmany diseases and disorders, including Alzheimer's disease,
amyotrophic lateral sclerosis, Huntington's disease, AIDS dementia
complex, malaria, cancer, depression and schizophrenia (Chen and
Guillemin, 2009).
QUIN is a co-agonist of the NMDA receptor subgroup containing the
NR2A andNR2B subunits (de Carvalho et al., 1996), with low receptor af-
ﬁnity. It is known that QA can cause excitotoxicity through a direct acti-
vation of NMDA receptors (Stone and Perkins, 1981) due to inhibition of
release and uptake of endogenous glutamate (Connick and Stone, 1988;
Tavares et al., 2002). In this context, it is generally accepted that excito-
toxic cell death elicited by QUIN involves bioenergetic failure resultingio Grande do Sul, Instituto de
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vier OA license.from Ca2+ overload and the generation of reactive oxygen species
(ROS) by mitochondria (Behan et al., 1999; Rios and Santamaria, 1991).
QUIN at high concentrations is an excitotoxin that produces a pat-
tern of cell death that mimics the selective neuronal vulnerability
seen in Huntington's disease patients with loss of striatal neurons
(Beal et al., 1986; Estrada Sanchez et al., 2008). Intrastriatal QUIN in-
jection has been used as a model of neurotoxicity loading striatal de-
generation, behavioral, biochemical and cellular alterations (Kalonia
et al., 2011a) and oxidative damage (Kalonia et al., 2011b).
The neuronal cytoskeleton comprises a protein network formed
mainly by microtubules (MT) and neuroﬁlaments (NF), the IFs of neu-
rons. NF, known as type IV IF, are composed of three different polypep-
tides whose approximate molecular weights are 200, 160, and 68 kDa,
and are commonly referred to as heavy (NFH), medium (NFM), and
light (NFL) NF subunits (Ackerley et al., 2003). Type III IF proteins in-
cludes vimentin, desmin, glial ﬁbrillary acidic protein (GFAP) and per-
ipherin. GFAP is the IF of mature astrocytes (Eng et al., 2000),
peripherin is found in neural cells of the peripheral nervous system,
and vimentin is the IF of cells of mesenchymal origin (Albert et al.,
2008). Otherwise, desmin constitutes the IF of muscle cells (Albert et
al., 2008). IFs play an important structural or tension-bearing role in
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framework for the modulation and control of essential cell processes,
in particular, signal transduction events (Kim and Coulombe, 2007;
Paramio and Jorcano, 2002).
Protein phosphorylation is themostwidespread type of posttransla-
tional modiﬁcation used in signal transduction (Ubersax and Ferrell,
2007) affecting basic cellular processes, including regulation of the
structural organization of the cytoskeleton (Fuchs and Weber, 1994;
Sihag et al., 2007). Accordingly, phosphorylation of types III and IV
(NF triplet proteins andα-internexin) IFs is known to regulate their or-
ganization and function (Sihag et al., 2007). IF proteins are known to be
phosphorylated on their head and tail domains. Type III ﬁlaments are
phosphorylated on head domain sites by second messenger-
dependent protein kinases and it is described that phosphorylation
plays a major role in regulating the assembly/disassembly of these ﬁla-
ments (Sihag et al., 2007). Similarly, the three subunits of NFs are highly
phosphorylated (Shea and Chan, 2008). Themajor sites of phosphoryla-
tion of NFL and NFM subunits were identiﬁed as Ser-55, which is phos-
phorylated by protein kinase A (PKA), Ser-57 phosphorylated by Ca2+/
calmodulin-dependent protein kinase II (PKCaMII), Ser-51 for protein
kinase C (PKC) (Gill et al., 1990; Heins et al., 1993), and Ser-23 for
PKA and protein kinase C (PKC), respectively (Daile et al., 1975; Kemp
et al., 1975). Nonetheless, PKCaMII is able to phosphorylate head do-
main sites on NFL subunit in vitro (Songyang et al., 1994). On the
other hand, most of the phosphorylation sites on NFM and NFH are lo-
cated on multiple lysine-serine-proline (KSP) repeat motifs abundant
in the carboxyl-terminal tail domain of these NF subunits (Geisler et
al., 1987; Lee et al., 1988; Xu et al., 1992). It is now evident that
proline-directed kinases, such as cyclin-dependent kinase 5 (Cdk5)
and mitogen-dependent protein kinase (MAPK) are the main kinases
that phosphorylate Ser residues on the KSP repeats (Jaffe et al., 1998;
Sun et al., 1996; Veeranna et al., 1998). The C-terminal regions of NFH
and NFM protrude laterally from the ﬁlament backbone when phos-
phorylated (Sihag et al., 2007) and a considerable body of evidence,
supports the notion that phosphorylation of C-terminal side arms, in
particular those of NFH, regulates NF axonal transport (Shea and
Chan, 2008). This is in concern with the evidence that carboxyl-
terminal phosphorylation of NFH progressively restricts association of
NFs with the anterograde motor kinesin, providing one mechanism by
which the NF axonal transport is slowed (Yabe et al., 2000). In fact, per-
ykarial accumulations/aggregations of aberrantly phosphorylated NFs
are a pathological feature of several humanneurodegenerative diseases,
such as Alzheimer's disease,motor neuron diseases and Parkinson's dis-
ease (Grant and Pant, 2000; Lariviere and Julien, 2004; Nixon, 1993;
Nixon and Sihag, 1991; Sasaki et al., 2006).
In this context, we have recently described that acute intrastriatal
administration of QUIN targets the phosphorylating system associated
with the cytoskeleton of neural striatal cells, causing IF hyperphosphor-
ylation 30 min after injection (Pierozan et al., 2010). Theseﬁndings sug-
gested the participation of QUIN-elicited transduction pathways
targeting the cytoskeleton. Therefore, misregulation of the phosphory-
lating system associated with IF proteins could represent an early step
in the pathophysiological cascade of deleterious events exerted by
QUIN in rat striatum. However, the cell signaling cascades in QUIN-
induced IF hyperphosphorylation are incompletely understood. To ex-
tend the scope of our previous ﬁndings, the purpose of the present
study was to elucidate the signaling mechanisms provoking hyperpho-
sphorylation of IF proteins focusing in the differential pathways attain-
ing neuronal and glial cells in striatal slices exposed to QUIN.
Materials and methods
Radiochemical and compounds
[32P]Na2HPO4 was purchased from Comissão Nacional de Energia
Nuclear (CNEN), São Paulo, Brazil. Quinolinic acid, 1,2-bis (2-aminophenoxy) ethane-N-N-N′-N′-tetraacetic acid tetrakis (acetoxy-
methyl ester) (BAPTA-AM), D-2-amino-5-phosphonopentanoic acid
(DP-AP5), ethylene glycol tetraacetic acid (EGTA), verapamil hydro-
chloride, dantrolene, phaclophen, bicuculine, staurosporine, benzami-
dine, leupeptin, antipain, pepstatin, chymostatin, acrylamide, bis-
acrilamide, SP600125, and roscovitine were obtained from Sigma (St.
Louis, MO, USA). KN-93, PD98056 and H89 were obtained from Calbio-
chem (La Jolla CA, USA). Anti-pNFL(Ser55), anti-pNFL(Ser57) and p38
inhibitor were from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX), (S)-α-methyl-4-car-
boxyphenylglycine (MCPG), 2-methyl-6-(phenylethynyl)pyridine hy-
drochloride (MPEP) and (S)-4-carboxy-3-hydroxyphenylglycine
(4C3HPG) were obtained from Tocris Bioscience (Ellisville, Missouri,
USA). Pictrotoxin was obtained from TCI America (Portland, OR, USA).
The antibody NFH (anti-KSP repeats) was from Chemicon (Temecula,
CA, USA). The chemiluminescence ECL kit peroxidase and the conjugat-
ed anti-rabbit IgG were obtained from Amersham (Oakville, Ontario,
Canada). All other chemicals were of analytical grade.Animals
Thirty-day-old Wistar rats obtained from Central Animal House of
the Departament of Biochemistry Federal University of Rio Grande do
Sul, Porto Alegre, Brazil, were used in the experiments. The animals
were maintained on a 12:12 h light/dark cycle in an air-conditioned
constant temperature (22 °C±1 °C) colony room, with food and
water at libitum. The experimental protocol followed the “Principles
of Laboratory Animal Care” (NHI publication 85-23, revised 1985)
and was approved by the Ethics Committee for Animal Research of
the Federal University of Rio Grande do Sul.Preincubation
Rats were sacriﬁced by decapitation, the striatum was dissected
onto Petri dishes placed on ice and cut into 400 μm thick slices with
a McIlwain chopper. Tissue slices were initially preincubated at
30 °C for 10 min in a Krebs-Hepes medium containing 124 mM
NaCl, 4 mM KCl, 1.2 mM,MgSO4, 25 mM Na–Hepes (pH 7.4), 12 mM
glucose, 1 mM CaCl2, and the following protease inhibitors: 1 mM
benzamidine, 0.1 μM leupeptin, 0.7 μM antipain, 0.7 μM pepstatin
and 0.7 μM chymostatin in the presence or absence of 100 mM DL-
AP5, 50 μM BAPTA-AM, 1 mM EGTA, 30 μM verapamil, 50 μM dantro-
lene, 10 μM KN93, 1 μM staurosporine, 30 μM PD98059 and 10 μM
U73122 (Loureiro et al., 2008), 50 μM CNQX, 100 μM MCPG
(Loureiro et al., 2005), 10 μM H89 (Cortes et al., 2010), 30 μM
SP600125 (Katayama et al., 2009), 10 μM p38 MAPK inhibitor VIII
(Rigon et al., 2008), 10 μM roscovitine (Tomizawa et al., 2002),
20 μM bicuculine and 100 μM picrotoxin (Adermark et al., 2010),
10 μM phaclofen (Seto et al., 2002), 30 μM MPEP hydrochloride
(Domenici et al., 2004) and 30 μM (S)-4-carboxy-3-hydroxyphenyl-
glycine (Orlando et al., 2001), when indicated.Incubation
After preincubation, the medium was changed by 100 ml of the
basic medium with or without 100 μM QUIN and/or the inhibitors
cited above, and incubation was carried out for 20 min at 30 °C.
After this, 100 μCi of [32P]-orthophosphate was added to the incuba-
tion medium and the labeling reaction was allowed to proceed for
30 min at 30 °C. Reaction was stopped with 1 ml of cold stop buffer
(150 mM NaF, 5 mM, EDTA, 5 mM EGTA, 50 mM Tris–HCl, pH 6.5,
and the protease inhibitors described above). Slices were then
washed twice with stop buffer to remove excess radioactivity.
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tissue slices
After treatment, preparations of IF-enriched cytoskeletal fractions
were obtained from striatum of rats as previously described by us
(Funchal et al., 2003). Brieﬂy, after the labeling reaction, slices were ho-
mogenized in 400 ml of ice-cold high salt buffer containing 5 mM
KH2PO4, (pH 7.1), 600 mM KCl, 10 mM MgCl2, 2 mM EGTA, 1 mM
EDTA, 1% Triton X-100 and the protease inhibitors described above.
The homogenate was centrifuged at 15,800×g for 10 min at 4 °C, in
an Eppendorf centrifuge, the supernatant discarded and the pellet ho-
mogenized with the same volume of the high salt medium. The resus-
pended homogenate was centrifuged as described and the
supernatant was discarded. The Triton-insoluble IF-enriched pellet,
containing NF subunits and GFAP, was dissolved in 1% SDS.
Total tissue homogenate
Tissue slices from striatum were homogenized in 100 ml of a lysis
solution containing 2 mM EDTA, 50 mM Tris–HCl, pH 6.8, 4% (v\v)
SDS. For electrophoresis analysis, samples were dissolved in 25% (v\v)
of solution containing 40% glycerol, 5% mercaptoethanol, 50 mM Tris–
HCl, pH 6.8 and boiled for 3 min.
Cell integrity
Measurement of cell integrity was determined by lactate dehydro-
genase (LDH) activity using a colorimetric commercial kit (from
Doles, Brazil), (Whitaker and McKay, 1969). Total LDH activity was
determined after adding a ﬁnal concentration of 10% Triton X-100
and disrupting the slices by homogenization with a Tissue Tearor
(Biospec). Results were expressed as percentage relative to 100%
LDH activity.
Cell viability
Mitochondrial dehydrogenase activity to reduce MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was used
to determine cell survival (Liu et al., 1997). The tetrazolium ring of
MTT is cleaved by various dehydrogenase enzymes in active mito-
chondria and then precipitated as a blue formazan product. Striatal
slices were incubated with MTT (0.5 mg/mL) in KRB buffer, pH 7.4
(122 mM Na-gluconate, 5 mM K-gluconate, 2 mM HEPES, 25 mM
NaHCO3, 1 mM MgSO4, 1.2 mM NaH2PO4, 0.9 mM Ca-gluconate,
1 mM L-glutamine, 5 mM glucose; KRB buffer) for 20 min at 37 °C.
The medium was then aspirated, the precipitated formazan was solu-
bilized with dimethyl sulfoxide, and viable cells were quantiﬁed spec-
trophotometrically at a wavelength of 550 nm.
Polyacrylamide gel electrophoresis (SDS-PAGE)
The cytoskeletal fraction and total tissue homogenate were pre-
pared as described above. For electrophoresis analysis, samples
were dissolved 25% (v/v) in a solution containing 40% glycerol, 5%
mercaptoethanol, 50 mM Tris–HCl, pH 6.8 and boiled for 3 min. Sam-
ples containing equal protein content (50 μg) were loaded onto 7% or
10% polyacrylamide gels and analyzed by SDS-PAGE according to the
discontinuous system of Laemmli (Laemmli, 1970). In the in vitro 32P
incorporation experiments, the gels containing the IF-enriched cyto-
skeletal fraction were exposed to X-ray ﬁlms (T-mat G/RA) at
−70 °C with intensifying screens and ﬁnally the autoradiograph
was obtained. Cytoskeletal proteins were quantiﬁed by scanning the
ﬁlms with a Hewlett-Packard Scanjet 6100C scanner and determining
optical densities with an Optiquant version 02.00 software (Packard
Instrument Company). Optical density values were obtained for the
band corresponding to each protein. Protein loading was controlledby Comassie blue R staining or actin immunoblotting. All bands
being measured were within the linear range of the ﬁlm.
Western blot analysis
Cytoskeletal fractions (50 μg) were analyzed by SDS-PAGE and
transferred to nitrocellulosemembranes (Trans-blot SD semi-dry trans-
fer cell, BioRad) for 1 h at 15 V in transfer buffer: 48 mMTrizma, 39 mM
glycine, 20% methanol and 0.25% SDS. The nitrocellulose membranes
were washed for 10 min in Tris buffered saline (TBS; 0.5 M NaCl,
20 mMTrizma and pH7.5), followed by 2 h incubation in blocking solu-
tion (TBS plus 5% defatted dried milk). After incubation, the blots were
washed twice for 5 min with TBS plus 0.05% Tween-20 (T-TBS), and
then incubated overnight at 4 °C in blocking solution containing the fol-
lowing monoclonal antibodies: anti-p-NFL(Ser55) diluted 1:800, anti-
p-NFL(Ser57) diluted 1:800, anti-NFH/NFM KSP repeats diluted 1:100
and anti-β-actin diluted 1:1000. The blot was then washed twice for
5 min with T-TBS and incubated for 2 h in TBS containing peroxidase
conjugated rabbit anti-mouse IgG or anti-rabbit IgG diluted 1:2000. In
addition, we used the following negative controls: antibody negative
control (lacking the sample containing the antigen of interest) and sam-
ple negative control (lacking the ﬁrst antibody). These controls (not
shown) stated the speciﬁcity and sensibility of the antibodies. The blot
was washed twice again for 5 min with T-TBS and twice for 5 min
with TBS. The blot was then developed using a chemiluminescence
ECL kit and quantiﬁed as described above.
Protein determination
The protein concentration was determined by the method of Lowry
(Lowry et al., 1951) using serum bovine albumin as the standard.
Statistical analysis
Data were analyzed statistically by one-way analysis of variance
(ANOVA) followed by the Tukey-Kramer post hoc comparison when
the F-test was signiﬁcant. A pb0.05 was considered signiﬁcant. All an-
alyses were performed using the SPSS software program on an IBM-
PC compatible computer.
Results
We initially evaluated the cell integrity of mitochondrial damage in
our experimental model, measuring LDH extracellular activity andMTT
which indicates overall mitochondrial dehydrogenase activity, respec-
tively. Our results showed that the in vitro treatment with 100 μM
QUIN preserved cell integrity and viability in striatal slices of 30 day-
old rats (results not shown). Thereafter, we studied the effect of QUIN
on the phosphorylation of IF-enriched cytoskeletal fraction of striatal
slices. Results showed that after 50 min exposition to 100 μM QUIN
the phosphorylation level of NF subunits (NFL, NFM and NFH) and
GFAP was increased (Fig. 1), suggesting that the cytoskeleton of both
neurons and astrocytes of striatal slices is an important in vitro target
of QUIN at a concentration described to be neurotoxic (Perez-De La
Cruz et al., 2010).
Action of QUIN on the second messenger-dependent and -independent
kinases targeting the IF proteins in astrocytes and neurons of striatal
slices
Since it is described that the secondmessenger-dependent protein
kinases are able to phosphorylate sites at GFAP and NFL head domains
(Hisanaga et al., 1990; Sihag and Nixon, 1989; Sihag et al., 2007), we
focused on the role of PKA, PKCaMII and PKC mediating the action of
QUIN on the phosphorylation level of these IF subunits. Results
showed that H89 (PKA inhibitor) and KN93 (PKCaMII inhibitor)
Fig. 1. Effect of QUIN on the phosphorylation of intermediate ﬁlament subunits in the cytoskeletal fraction from slices of striatumof 30-day-old rats. A) Sliceswere incubatedwith 100 μM
of QUIN in the presence of 32P-orthophosphate. The cytoskeletal fraction was extracted and the radioactivity incorporated into NFL, NFM, NFH and GFAP was measured as described in
Materials andmethods. Data are reported asmean±S.D. of 18 animals in each group and expressed as percent of controls. Statistically signiﬁcant differences from controls, as determined
by one-way ANOVA followed by Tukey–Kramer multiple comparison test are indicated: ***pb0.001compared with control and ###pb0.001 compared with QUIN group. B) Coomassie
blue stained molecular weight standards and representative stained gel of a control and a treated sample; C) corresponding autoradiograph. Equal amounts of the cytoskeletal fraction
(50 μg) from control (C) and treated (T) samples were run in 7.5% polyacrylamide gel electrophoresis. MW: molecular weight standard proteins.
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the QUIN-induced NFM and NFH hyperphosphorylation. Conversely,
staurosporine, a speciﬁc PKC inhibitor, was ineffective in preventing
GFAP hyperphosphorylation and only partially prevented this effect
on NFL (Fig. 2A).Fig. 2. Involvement of protein kinases on QUIN-induced IF in vitro hyperphosphorylation in
kinases PKA, PKCaMII and PKC was tested by using the speciﬁc inhibitors 10 μM H89, 1
p38MAPK and Cdk5 was tested using the speciﬁc inhibitors 30 μM PD9859, 30 μM SP60012
bated in the presence or absence of inhibitors for 10 min followed by incubation with 100 μM
out 100 μM QUIN and/or inhibitors, as described in Materials and methods. The cytoskeletal
was measured. Data are reported as means±S.D. of 18 animals in each group and expressed
way ANOVA followed by Tukey–Kramer multiple comparison test are indicated: ***pb0.
#pb0.05 compared with QA group.In order to identify the kinases targeting the phosphorylating sites
on NFM and NFH subunits, we used speciﬁc MAP kinases and Cdk5 in-
hibitors. Results showed that PD98059, a MAPKK (MEK) inhibitor and
p38 MAPK inhibitor VIII were not able to prevent the QUIN-induced
NFM and NFH hyperphosphorylation, while SP600125, a JNK inhibitorstriatum of 30 day-old rats. (A) Participation of second messenger dependent protein
0 μM KN93 and 1 μM staurosporina, respectively. (B) Participation of MEK/ERK, JNK,
5, 10 μM p38 MAPK inhibitor and 10 μM roscovitine, respectively. Slices were preincu-
QUIN for 20 min. After, slices were incubated with 32P-orthophosphate with or with-
fraction was extracted and the radioactivity incorporated into NFL, NFM, NFH and GFAP
as % of control. Statistically signiﬁcant differences from controls, as determined by one-
001; **pb0.01; *pb0.05 compared with control group; ###pb0.001; ##Pb0.01 and
Fig. 3. Effect of QA and different inhibitors on QA-hyperphosphorylation of speciﬁc
sites of NF. (A) Effect on QUIN-hyperphosphorylation of NFL(Ser55) and NFL(Ser57)
of striatum of rats. H89 (10 μM), KN93 (10 μM), 4-C3-HPG (30 μM) are incubated in
slices before QUIN, as described in Material and Methods. The cytoskeletal fraction
was extracted and the immunocontent of phosphoNFL(Ser55) and phosphoNFL(Ser57)
was measured. (B) Effect of QUIN on immunocontent of phosphoNFH(KSP repeats) in
slices of striatum of rats. Roscovitine (10 μM) and MPEP (30 μM) are incubated in slices
before QUIN, as described in Materials and methods. The cytoskeletal fraction was
extracted and the immunocontent of phosphoNFH(KSP repeats) was measured. Densito-
metric data are shown. Representative immunoblots are represented. Results are
expressed asmean±S.D. Statistical analysis: one-way ANOVA followed by Tukey–Kramer
test is indicated: ***pb0.001 compared with control group and ###pb0.001 compared
with QUIN group.
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lation. Furthermore, roscovitine, a Cdk5 inhibitor (Zhou et al., 2010)
totally prevented NFM and NFH hyperphosphorylation (Fig. 2B).
QUIN-induced signaling pathways targeting speciﬁc phosphorylating
sites on NF subunits in striatal slices
In an attempt to identify the phosphorylating sites targeted by QUIN
on NFL head domain, we assayed the immunoreactivity of NFLSer55
and NFLSer57 for PKA and PKCaMII, described to be regulatory sites
for the NF assembly (Grant and Pant, 2000). Western blot assays
showed that the immunoreactivity with anti-phosphoSer55 and anti-
phosphoSer57 antibodies was increased in the cytoskeletal fraction of
striatal slices exposed to QUIN. Moreover, phosphorylation of NFLSer55
was prevented byH89 and phosphorylation of NFLSer57was prevented
by KN93, PKA and PKCaMII inhibitors, respectively (Fig. 3A). Moreover,
the KSP repeats, located in the NFH tail domain were the targets for the
action of QUIN, as demonstrated by Western blot assay with anti-
phosphoKSP repeat antibody. Interestingly, QA-induced phosphoryla-
tion of KSP repeatswas totally prevented byMPEP (mGluR5 antagonist)
and roscovitine, suggesting that QUIN would be upstream of mGluR5,
which in turn, would activate cdk5 provoking hyperphosphorylation
of the KSP repeat sites in the NFH tail domain (Fig. 3B).
Participation of neurotransmitters in the action of QUIN in striatal slices:
Testing the roles of glutamatergic and GABAergic systems
Since QUIN is considered a NMDA glutamate agonist (Schwarcz and
Pellicciari, 2002; Stone, 1993), we assayed the participation of gluta-
mate receptors in the action of QUIN on the phosphorylating system as-
sociated with the IFs of the striatal neural cells. Tissue slices were
coincubated with QUIN and DL-AP5, a competitive NMDA ionotropic
antagonist, CNQX, a nonNMDA ionotropic antagonist and MCPG, a
metabotropic glutamate antagonist. As shown in Fig. 4, hyperphosphor-
ylation induced by QUINwas totally prevented in the IF subunits by the
NMDA antagonist, while CNQX attenuated the effect of QUIN on NFL. In
addition, the metabotropic glutamate antagonist MCPG attenuated the
action of QUIN on NFM. To further identify the types of mGluR involved
in such action, we tested 4-C3-HPG and MPEP, speciﬁc mGluR1 and
mGluR5 antagonists, respectively. Results showed that mGluR1 inhibi-
tion totally prevented the QUIN-induced hyperphosphorylation of NFL
head domain sites. In addition, mGluR5 inhibition prevented the hyper-
phosphorylation of KSP repeats on NFM and NFH and partially in the
head domain sites on NFL. Taken together, these ﬁndings suggest the
participation of mGluRs in the action caused by QUIN on the dynamic
phosphorylation of NF subunits.
We also, tested the involvement of the GABAergic system on the ac-
tion of QUIN in vitro on the striatal tissue, since we have previously
demonstrated that this neurotransmitter system was involved in the
dynamics of the phosphorylating system associatedwith the IF proteins
in brain slices (Funchal et al., 2004). Moreover, Rekik et al. (2011)
reported increased GABAB1 or GABAB2 immunoreactivity in the lesioned
striatum after QUIN injection. In line with this, Fujiyama et al. (2002)
described upregulation of GABAA receptors in the substantia nigra of
rats that have received intrastriatal QUIN injection. However, results
obtained in the present study with the speciﬁc antagonists for GABAA
(bicuculine and pictrotoxin) and GABAB (phaclofen) receptors, respec-
tively, indicated that IF hyperphosphorylation induced by QUIN was
not mediated by the GABAergic system in striatal slices (results not
shown).
Roles of Ca2+mediating the actions of QUIN on the phosphorylating system
associated with the cytoskeleton
Taking into account the relevance of Ca2+ in the intracellular events
that result in the regulation of cell function, particularly in whatconcerns to the cytoskeletal phosphorylation system (Funchal et al.,
2004, 2005a,b; Loureiro et al., 2008; Stull, 2001), we examined the in-
volvement of Ca2+ in the QUIN-mediated increase of the in vitro 32P in-
corporation into IF in rat striatum. To test the involvement of Ca2+
inﬂux through voltage-dependent Ca2+ channels (VDCC), we used
the speciﬁc L-VDCC blocker verapamil. Results showed that co-
incubation of the tissue slices with QUIN and verapamil totally pre-
vented the effect of QUIN on the phosphorylating system, suggesting
that Ca2+ inﬂux via L-VDCC was involved in the ability of QUIN to
alter the phosphorylating/dephosphorylating equilibrium of IF proteins
recovered in the cytoskeletal fraction. To further investigate the role of
intra and extracellular Ca2+ levels in this process we performed exper-
iments using EGTA, as an extracellular Ca2+ chelator and BAPTA-AM
the membrane-permeable form of BAPTA, an intracellular Ca2+ chela-
tor (Tymianski et al., 1994). In the experiments designed to verify the
involvement of the Ca2+ release from the intracellular stores we used
dantrolene, an inhibitor of ryanodine Ca2+ channels of the endoplasmic
reticulum. Taken together, the results showed that the action of QUIN
was dependent on the cytosolic Ca2+ levels and on the Ca2+ inﬂux
from externalmedium in both neuronal and glial cells. In addition, dan-
trolene at a concentration described to irreversibly inhibit ryanodine
channel opening (Serysheva and Hamilton, 1998), prevented the IF
Fig. 4. Involvement of glutamate receptors on QUIN-induced IF hyperphosphorylation in striatum of 30-day-old rats. Slices were preincubated for 20 min in the presence of 100 μM
DL-AP5, 50 μM CNQX, 100 μMMCPG, 30 μMMPEP, 30 μM 4C3HPG and incubated with 100 μM of QUIN for 30 min. After, the slices were incubated with 32P-orthophosphate with or
without the blockers and/or 100 μM QUIN. The cytoskeletal fraction was extracted and the radioactivity incorporated into NFL, NFM, NFH and GFAP was measured. Data are
reported as means±S.D. of 18 animals in each group and expressed as percent of control. Statistically signiﬁcant differences as determined by one-way ANOVA followed by
Tukey–Kramer multiple comparison test are indicated: ***pb0.001; **pb0.01 and *pb0.05 compared with control; ###pb0.001; ##pb0.01 and #pb0.05 compared with QUIN
group.
396 P. Pierozan et al. / Experimental Neurology 233 (2012) 391–399hyperphosphorylation induced by QUIN (Fig. 5), in neurons, but not in
astrocytes, which is consistent with the presence of these channels in
excitable cell types, such as muscle and neurons (Bennett et al., 1996).
Finally, to characterize the role of phospholipase C in the QUIN-
activated signaling pathways targeting the IF-associated phosphory-
lating system, we used U73122, a speciﬁc PLC inhibitor. Results
showed a partial involvement of PLC in the phosphorylation level of
NFL, compatible with a role of diacylglycerol (DAG) in the activation
of PKC and phosphorylation of head-domain phosphorylating sites
on NFL (Fig. 2).
Discussion
We have recently demonstrated that intrastriatal QUIN injection
provoked the disruption of the homeostasis of the phosphorylating
system associated with the cytoskeleton in neurons and in astrocytes
of 30-day-old rats and that this effect was mediated by Ca2+ inﬂux
through NMDA channels and by oxidative stress. We then proposed
that alterations of the phosphorylation system associated with the
IF proteins could represent an early event on the cascade of neurode-
generation mediated by QUIN in vivo (Pierozan et al., 2010). Taking
into account these ﬁndings and the relevance of the cytoskeleton in
the physiology and pathophysiology of neural cells, we were interest-
ed to assess the molecular mechanisms underlying the actions of
QUIN on the phosphorylating system associated with the cytoskele-
ton in the striatal astrocytes and neurons. Therefore, in the presentFig. 5. Involvement of intra and extracellular Ca2+ and phospholipase C on QUIN-induced IF
BAPTA-AM, 1 mM EGTA, 30 μM verapamil, 30 μM dantrolene and 10 μM U73122 and incub
phosphate with or without the blockers and/or 100 μM QUIN. The cytoskeletal fraction was
sured. Data are reported as means±S.D. of 18 animals in each group and expressed as per
followed by Tukey–Kramer multiple comparison test are indicated: ***pb0.001; **pb0.01
with QUIN group.report we used an in vitro model in which striatal slices of 30-day-
old rats were exposed to 100 μM QUIN for 50 min demonstrating
that QUIN, at a concentration described to induce excitotoxic effects
in striatal slices (Perez-De La Cruz et al., 2010), is upstream of com-
plex signaling pathways provoking hyperphosphorylation of GFAP,
the IF protein from mature astrocytes, as well as of NFL, NFM and
NFH, constituents of neuronal IFs.
It was found that QUIN disrupted the homeostasis of the cytoskel-
eton of astrocytes and neurons by cell speciﬁc mechanisms. In astro-
cytes, the action of QUIN was mediated by increased Ca2+ inﬂux
through NMDA and L-VDCC channels. High Ca2+ levels in the cytosol
induced hyperphosphorylation of GFAP, by the second messenger-
dependent protein kinases PKA and PKCaMII. These ﬁndings are in
agreement with the previous evidence showing that the neural iso-
forms of adenylyl cyclase are activated by Ca2+, supporting the PKA
activation by high Ca2+ levels (Steiner et al., 2006). It is of note that
PKCaMII is a Ca2+/calmodulin protein kinase implicated in the phos-
phorylation of sites in the head domain of type III IF proteins, includ-
ing GFAP (Leal et al., 1997; Omary et al., 2006).In this context,
phosphorylation of the head domain of homopolymeric ﬁlaments
like vimentin, desmin and GFAP is known to be important for ﬁla-
ment assembly and plays a special role in dividing cells. Therefore, ab-
normal phosphorylation of the head domain sites of these type III IF
proteins could lead to nonphysiological disassembly of IFs contribut-
ing to disruption of cell homeostasis (Gill et al., 1990; Heins et al.,
1993).in vitro phosphorylation. Slices were preincubated for 20 min in the presence of 50 μM
ated with 100 μM of QUIN for 30 min. After, the slices were incubated with 32P-ortho-
extracted and the radioactivity incorporated into NFL, NFM, NFH and GFAP was mea-
cent of control. Statistically signiﬁcant differences as determined by one-way ANOVA
; *pb0.05 compared with control; ###pb0.001; ##pb0.01 and #pb0.05 compared
397P. Pierozan et al. / Experimental Neurology 233 (2012) 391–399In neurons QUIN elicited more complex actions involving metabo-
tropic glutamate receptors and the release of Ca2+ from intracellular
stores besides Ca2+ inﬂux throughNMDA and L-VDCCmembrane chan-
nels. These events resulted in the hyperphosphorylation of both head-
domain sites on NFL and tail-domain sites on NFM and NFH proteins.
It was observed that in QUIN-induced hyperphosphorylation of NFL
head domain sites was mediated by PKC, PKA and PKCaMII. NFL hyper-
phosphorylationwas partially prevented by themGluR1 antagonist and
by inhibiting PLC activity. These ﬁndings indicate that QUIN is upstream
of mGluR1/PLC pathway implicated in the hydrolysis of phosphatidyl
inositol 4,5-biphosphate (PI(4,5)P2) in neurons, producing inositol
1,4,5-triphosphate (IP3) and diacylglycerol (DAG) which, in turn, is
able to activate PKC. Moreover, the use of site- and phosphorylation
state-speciﬁc antibodies, as well as protein kinase inhibitors, pointed
to PKA phosphorylating NFL subunit on Ser55 and PKCaMII phosphory-
lating NFL on Ser57. Differently from homopolymeric ﬁlaments, phos-
phorylation of the head domain sites on NFL was not involved in
ﬁlament disassembly. NFs are present in the postmitotic neurons, and
once formed, do not undergo depolymerization (Sihag et al., 2007).
Thus, the roles of head domain phosphorylation of rat NFL and NFM
are thought to be related to the obligate heteropolymeric NF ﬁlament
formation (Ching and Liem, 1999), suggesting, therefore, that QUIN
neurotoxicity in striatal slices includes destabilization of the IF network
of neuronal cells. In this context, we have previously demonstrated that
hyperphosphorylation of NFL on Ser55 is on the basis of neuronal dys-
function related to congenital hypothyroidism (Zamoner et al., 2008a).
Moreover, the KSP repeats located on NFM and NFH carboxyl-
terminal tail domains were hyperphosphorylated by cdk5, while JNK/
MAPK only partially contributed to NFM hyperphosphorylation in re-
sponse to the QUIN insult. In this context, it has been described that
Cdk5 phosphorylates cytoskeletal proteins, including the NFs and the
microtubule associated protein Tau (Ackerley et al., 2003; Bu et al.,
2002; Pant et al., 1997; Shea et al., 2004; Zhou et al., 2010). Cdk5 is a
member of the Cdk family, whose activity is predominantly detected
in post-mitotic neurons (Hisanaga and Saito, 2003). Two related pro-
teins, p35 and p39, activate Cdk5 upon direct binding. During neurotox-
ic stress, intracellular rise in Ca2+ activates calpain, which cleaves p35
to generate p25. The long half-life of Cdk5/p25 results in a hyperactive
aberrant Cdk5 that hyperphosphorylates Tau, NF and other cytoskeletal
proteins (Hisanaga and Saito, 2003). It is known that carboxyl-terminal
phosphorylation of NFH progressively restricts the association of neuro-
ﬁlaments with kinesin, the axonal anterograde motor protein, andFig. 6. Proposed mechanism by which QUIN activates IF phosphorylation in neural cells of str
of Ca2+ through NMDA receptors and L-VDCC, together with Ca2+ release from intracellula
including activation of PKA, PKCaMII and PKC, which phosphorylate head domain sites on G
KSP repeats of NFM and NFH, and mGluR1 is upstream of PLC which produces DAG which,stimulates its interactionwith dynein, the axonal retrogrademotor pro-
tein (Motil et al., 2006). This event could represent one of the mecha-
nisms by which carboxyl-terminal phosphorylation would slow
neuroﬁlament axonal transport. These hyperphosphorylated cytoskele-
tal proteins set the groundwork to forming neuroﬁbrillary tangles and
aggregates of phosphorylated proteins, that are hallmarks of neurode-
generative diseases like Alzheimer's disease, Parkinson's disease and
Amyotropic Lateral Sclerosis (Kanungo et al., 2008).
Proline-directed Cdk5 andMAP kinases are among themain proline-
directed kinases phosphorylating Ser residues on KSP tail domain on
the NFM and NFH (Jaffe et al., 1998; Sun et al., 1996; Veeranna et al.,
1998) in response to signal transduction cascades triggered by a variety
of signals (Dashiell et al., 2002; DeFuria and Shea, 2007; Li et al., 1999a,
2000), including Ca2+ inﬂux (Li et al., 1999b). It is important to note
that our results showing that QUIN induced NFM and NFH hyperpho-
sphorylation was mediated by cdk5 while Erk and p38MAPK were not
involved in this effect, and JNK partially phosphorylated NFM subunit.
These ﬁndings could be correlated with cdk5-induced inactivation of
the MAPK pathway (Li et al., 2002; Sharma et al., 2002).
In the neuronal cells the glutamate receptors were also important
mediators of the neurotoxicity of QUIN in striatal slices. We observed
that hyperphosphorylation of NFL, NFM and NFH was dependent on
NMDA as well as group I metabotropic glutamate receptors (mGluR1
and mGluR5), but not on AMPA and kainate receptors. However, we
cannot exclude the possibility that QUIN-induced increase of IF phos-
phorylation through mGLUR could be due to and indirect effect of
QUIN causing glutamate release. In this context, although Connick and
Stone (1988) have described that high concentrations (2 mM and
higher) of QUIN were able to release glutamate in vivo, this metabolite
failed to induce glutamate release in concentrations as high as 5 mM
in vitro. Therefore it is improbable that glutamate release could be pro-
voked by QUIN (100 μM) in our experimental conditions.
Activation of group I mGluRs by QUIN is consistent with a central
role of these receptors in the striatum, whereas activation of mGlu1
andmGlu5 receptors exerts distinct actions, depending on the neuronal
subtype involved (Bonsi et al., 2008). Consistently with our results, the
mGluR1/5 signal transduction is complex and involves multiple part-
ners leading to activation of a wide variety of signaling pathways. It is
noted that mGluRs coupled to Gα(q/)11 proteins activated phospholi-
pase Cβ1 resulting in DAG and IP3 formation is followed by PKC activa-
tion. In addition, mGluR activation can lead to modulation of a number
of ion channels, such as different types of Ca2+ and K+ channelsiatum of rats. The effects of QUIN are initiated by mGluR activation and excessive inﬂux
r stores leads to an overload of Ca2+ within the cell, which set off a cascade of events
FAP and NFL subunits. Cdk5 is activated downstream of mGluR5 phosphorylating the
in turn, activate PKC and phosphorylate NFL.
398 P. Pierozan et al. / Experimental Neurology 233 (2012) 391–399(Ribeiro et al., 2010). Also,mGluR5 is reported to be upstream of several
kinases, including cdk5 (Wang et al., 2004). Otherwise, activation of
NMDA receptors is implicated in the increased cytoplasmic Ca2+ con-
centrations, which in turn, can trigger a range of downstreamneurotox-
ic cascades, including the activation and overstimulation of protein
kinases (Szydlowska and Tymianski, 2010).
Regarding to the relevance of Ca2+ overload on the modulation of
the phosphorylating system associated with the cytoskeleton
(Heimfarth et al., 2010; Loureiro et al., 2005, 2010; Zamoner et al.,
2008b), the blockade of L-VDCC and the intra and extracellular Ca2+
chelation totally prevented the effect of QUIN on IF phosphorylation. In-
terestingly, dantrolene-induced inhibition of Ca2+ release from the en-
doplasmic reticulum through ryanodine receptors prevented this effect
in neurons but was ineffective in astrocyte IFs, reinforcing the cell type
speciﬁc signaling mechanisms. On the basis of our results QUIN in-
creased cytosolic Ca2+ in neural cells downstream of Ca2+ inﬂux
through NMDA, L-VDCC and Ca2+ release from intracellular stores.
These ﬁndings show the role of Ca2+ in the actions of QUIN on the
cytoskeleton.
Taking into account our experimental results we could reach to the
proposal depicted in Fig. 6, that the in vitro action of QUIN on the endog-
enous phosphorylating system targeting the cytoskeleton of striatal
cells is a complex intracellular process initiated by mGluR activation
and excessive inﬂux of Ca2+ through NMDA receptors and L-VDCC.
These events, together with Ca2+ release from intracellular stores
lead to an overload of Ca2+ within the cell. Elevated Ca2+ levels then
set off a cascade of events including activation of the second
messenger-dependent protein kinases PKA, PKCaMII and PKC, which
phosphorylate head domain sites on GFAP and NFL subunits and poten-
tially misregulating IF assembly in both glial and neuronal cells. It was
also found that Cdk5 is activated downstream of mGluR5, phosphory-
lating the KSP repeats on NFM and NFH. Also, mGluR1 is upstream of
PLC which, in turn, produces DAG and IP3. Our results are also in accor-
dance to the evidence that DAG is important to activate PKC and phos-
phorylate NFL, while IP3 contributes to Ca2+ release from internal
stores promoting hyperphosphorylation of KSP repeats on the tail do-
main of NFM and NFH. Besides the action on the phosphorylation sites
on IF subunits, Cdk5 is probably able to inhibit MAPK pathway. Taking
together, these signaling pathways eventually contribute to the fate of
the affected astrocytes and neurons exposed to QUIN.Acknowledgments
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